Recombinant Mouse ADRB1 Protein

Cat.No. : ADRB1-1385M
Product Overview : Recombinant Mouse ADRB1 full length or partial length protein was expressed.
  • Specification
  • Gene Information
  • Related Products
Source : Mammalian Cells
Species : Mouse
Tag : His
Form : Liquid or lyophilized powder
Endotoxin : < 1.0 EU per μg of the protein as determined by the LAL method.
Purity : >80%
Notes : This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
Storage : Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC.
Storage Buffer : PBS buffer
Gene Name : Adrb1 adrenergic receptor, beta 1 [ Mus musculus ]
Official Symbol : ADRB1
Gene ID : 11554
mRNA Refseq : NM_007419.2
Protein Refseq : NP_031445.2
UniProt ID : P34971

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.


  • Q&As
  • Reviews

Q&As (10)

Ask a question
Is there any risk associated with ADRB1-targeted therapies? 12/07/2021

Like all medical treatments, ADRB1-targeted therapies may have potential risks and side effects. For example, beta-blockers, which target ADRB1 proteins, can cause problems such as low blood pressure, slowed heart rate, and bronchospasm in some patients. Additionally, genetic testing for ADRB1 variants may raise ethical and privacy concerns. It is important for patients to discuss the potential benefits and risks of any therapy with their healthcare provider and to undergo genetic testing only when it is medically appropriate and authorized.

Are there any ongoing clinical trials involving ADRB1-targeted therapies? 10/27/2021

Yes, there are numerous ongoing clinical trials involving ADRB1-targeted therapies for various medical conditions, including heart failure, hypertension, and cancer. These trials are evaluating the safety and efficacy of new drugs that target ADRB1 proteins or existing drugs in combination with other agents. Results from these trials may lead to new treatment options for patients and improved understanding of the role of ADRB1 signaling in these conditions.

What other medical conditions are associated with ADRB1? 06/02/2020

In addition to heart disease and hypertension, ADRB1 has been implicated in other medical conditions such as asthma, diabetes, and obesity. Studies have suggested that genetic variations in the ADRB1 gene may play a role in the development or progression of these diseases. For example, some variants of ADRB1 have been linked to an increased risk of type 2 diabetes and impaired insulin sensitivity. Understanding the role of ADRB1 signaling in these conditions could lead to new therapeutic approaches.

How does ADRB1 signaling affect heart function? 11/29/2019

ADRB1 receptors are primarily expressed in the heart and are involved in regulating cardiac contractility and heart rate. Activation of ADRB1 receptors by epinephrine or norepinephrine leads to an increase in intracellular cAMP levels, which ultimately activates protein kinase A (PKA) and calcium channels in cardiac myocytes. This leads to an increase in calcium influx into the cell, which results in increased contractility and heart rate.

Can variations in the ADRB1 gene affect a person's response to medical treatment? 11/14/2019

Yes, variations in the ADRB1 gene can affect a person's response to drugs that target ADRB1 proteins, such as beta-blockers. For example, some studies have found that individuals with certain genetic variants of ADRB1 may have a reduced response to beta-blockers or an increased risk of side effects. Genetic testing may help identify individuals who are more likely to benefit from certain therapies or who may require a lower dose or alternative treatment.

How can ADRB1 research impact personalized medicine? 04/03/2019

ADRB1 research may help personalize medical treatment by identifying patients who are more likely to benefit from certain therapies or who may require alternative treatments based on their genetic and physiological factors. For example, some studies have suggested that genetic variations in ADRB1 may affect a person's response to beta-blockers or other ADRB1-targeted drugs, which can help guide treatment decisions. Additionally, taking into account a patient's individual ADRB1 signaling profile may help tailor treatment for optimal effectiveness and safety.

What are some promising avenues of research in ADRB1 signaling? 01/20/2019

Several areas of research have shown promise in furthering our understanding of ADRB1 signaling and its role in disease. One area of focus is on the identification of new ligands or compounds that specifically target ADRB1 proteins. These compounds could potentially provide more selective and effective therapies for various medical conditions. Another area of interest is on understanding the mechanisms by which ADRB1 signaling regulates metabolic processes, such as glucose uptake and lipid metabolism.

How does ADRB1 signaling influence metabolism? 11/28/2018

ADRB1 receptors are expressed in many metabolic tissues, including the liver, adipose tissue, and skeletal muscle. Activation of ADRB1 receptors in these tissues stimulates the breakdown of stored fat, leading to increased release of free fatty acids and increased energy expenditure. In the liver, activation of ADRB1 receptors also stimulates glycogenolysis, leading to increased glucose release into the bloodstream.

Can lifestyle factors influence ADRB1 expression or signaling? 02/07/2018

Yes, lifestyle factors such as diet, physical activity, and stress can influence ADRB1 expression and signaling. For example, exercise has been shown to increase ADRB1 expression in skeletal muscle, which may contribute to the metabolic benefits of physical activity. Similarly, dietary factors such as caffeine and alcohol can affect ADRB1 signaling and may interact with drugs that target ADRB1 proteins. Understanding how lifestyle factors impact ADRB1 signaling may help optimize treatment strategies for various medical conditions.

Can ADRB1 research lead to insights into other receptor signaling pathways? 06/28/2017

Yes, research on ADRB1 signaling may provide insights into other G protein-coupled receptor (GPCR) signaling pathways, which are involved in numerous physiological processes. GPCR signaling is a complex network of interactions with various downstream effectors and signaling pathways. Studies of ADRB1 may help identify common or divergent features of GPCR signaling and may lead to the discovery of new therapeutic targets for a range of diseases.

Customer Reviews (4)

Write a review

    This gives me confidence that they will continue to be a leader in their field and that I can trust their products for future experiments. -


      I am thoroughly satisfied with my experience working with this manufacturer and their high-quality protein. -


        the manufacturer has demonstrated a commitment to ongoing research and development, with a robust pipeline of new proteins in various stages of development. -


          The manufacturer has clearly prioritized quality control at every step of the process, from production to packaging to delivery, and their attention to detail is evident in the final product. -

          Ask a Question for All ADRB1 Products

          Required fields are marked with *

          My Review for All ADRB1 Products

          Required fields are marked with *


          Inquiry Basket


          Stay Updated on the
          Latest Bioscience Trends

          Copyright © 2023 Creative BioMart. All Rights Reserved.

          Terms and Conditions        Privacy Policy